Next Article in Journal
OSA Upper Airways Surgery: A Targeted Approach
Previous Article in Journal
Evaluation of Mortality and Morbidity According to Initial Symptoms in COVID-19 Patients Using Clinical Epidemiologic Data from the Korea Centers for Disease Control & Prevention
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Glutathione Reductase Is Associated with the Clinical Outcome of Septic Shock in the Patients Treated Using Continuous Veno-Venous Haemofiltration

1
Department of Internal Diseases, Riga Stradins University, LV-1079 Riga, Latvia
2
Clinic of Nephrology and Renal Replacement Therapy, Riga East University Hospital, LV-1079 Riga, Latvia
3
Clinic of Toxicology and Sepsis, Riga East University Hospital, LV-1079 Riga, Latvia
4
Scientific Laboratory of Biochemistry, Riga Stradins University, LV-1067 Riga, Latvia
5
Clinic of Internal Diseases, Riga East University Hospital, LV-1079 Riga, Latvia
6
Scientific Laboratory of Molecular Genetics, Riga Stradins Univerisy, LV-1007 Riga, Latvia
7
Department of Public Health and Epidemiology, Riga Stradins Univerisy, LV-1010 Riga, Latvia
*
Author to whom correspondence should be addressed.
Medicina 2021, 57(7), 689; https://doi.org/10.3390/medicina57070689
Submission received: 11 June 2021 / Revised: 30 June 2021 / Accepted: 1 July 2021 / Published: 6 July 2021
(This article belongs to the Section Emergency Medicine)

Abstract

Background and objectives: At present, there is insufficient evidence to support the use of continuous veno-venous haemofiltration (CVVH) in the early treatment of septic shock. This study focuses on the association between survival and different parameters of oxidative stress (RedOx). Thereby, we evaluated whether RedOx markers are associated with the outcome of septic shock in patients under early-initiated CVVH treatment. Materials and Methods: We conducted a prospective observational study of 65 patients with septic shock who started CVVH within 12 h after hospital admission. Blood samples were taken from each patient prior to the start of CVVH. The following RedOx markers were measured: glutathione peroxidase, glutathione reductase (GR), total antioxidant capacity, superoxide dismutase, nitric oxide, malondialdehyde and 4-hydroxynonenal. The odds ratio (OR) was calculated using binary logistic regression and stepwise multivariable regression. Results: The 65 patients had a median age of 66 years and 39 were male. Based on the outcome, the patients were divided into two groups—non-survivors (n = 29) and survivors (n = 36)—and the levels of RedOx markers were compared between them. Of all the markers, only higher GR activity was found to be significantly associated with the fatal outcome; 100.3 U/L versus 60.5 U/L, OR = 1.027 (95% CI, 1.010–1.044). Following adjustment for the sequential organ failure assessment score and other parameters, GR activity still presented a significant association with the fatal outcome, OR = 1.020 (95% CI, 1.002–1.038). Conclusions: GR activity is associated with in-hospital fatal outcomes among septic shock patients under early-initiated CVVH treatment. Septic shock patients who have a lower GR activity at hospital admission may have a favourable outcome of the early initiation of CVVH.
Keywords: glutathione reductase; oxidative stress; septic shock; continuous veno-venous haemofiltration glutathione reductase; oxidative stress; septic shock; continuous veno-venous haemofiltration

Share and Cite

MDPI and ACS Style

Moisejevs, G.; Bormane, E.; Trumpika, D.; Baufale, R.; Busmane, I.; Voicehovska, J.; Grigane, A.; Suba, O.; Silova, A.; Skesters, A.; et al. Glutathione Reductase Is Associated with the Clinical Outcome of Septic Shock in the Patients Treated Using Continuous Veno-Venous Haemofiltration. Medicina 2021, 57, 689. https://doi.org/10.3390/medicina57070689

AMA Style

Moisejevs G, Bormane E, Trumpika D, Baufale R, Busmane I, Voicehovska J, Grigane A, Suba O, Silova A, Skesters A, et al. Glutathione Reductase Is Associated with the Clinical Outcome of Septic Shock in the Patients Treated Using Continuous Veno-Venous Haemofiltration. Medicina. 2021; 57(7):689. https://doi.org/10.3390/medicina57070689

Chicago/Turabian Style

Moisejevs, Georgijs, Eva Bormane, Dace Trumpika, Regina Baufale, Inara Busmane, Julija Voicehovska, Anda Grigane, Olegs Suba, Alise Silova, Andrejs Skesters, and et al. 2021. "Glutathione Reductase Is Associated with the Clinical Outcome of Septic Shock in the Patients Treated Using Continuous Veno-Venous Haemofiltration" Medicina 57, no. 7: 689. https://doi.org/10.3390/medicina57070689

APA Style

Moisejevs, G., Bormane, E., Trumpika, D., Baufale, R., Busmane, I., Voicehovska, J., Grigane, A., Suba, O., Silova, A., Skesters, A., Lejnieks, A., Gailite, L., & Brigis, G. (2021). Glutathione Reductase Is Associated with the Clinical Outcome of Septic Shock in the Patients Treated Using Continuous Veno-Venous Haemofiltration. Medicina, 57(7), 689. https://doi.org/10.3390/medicina57070689

Article Metrics

Back to TopTop